REFERENCES
- Lowy F D, Hammer S M. Staphylococcus epidermidis infections. Ann Intern Med. 1983; 99: 834–839, [PUBMED], [INFOTRIEVE], [CSA]
- Benz M S, Scott I U, Flynn H W, Jr, et al. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol. 2004; 137: 38–42, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Huebner J, Goldmann D A. Coagulase-negative staphylococci: role as pathogens. Annu Rev Med. 1999; 50: 223–236, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Perkins R E, Kundsin R B, Pratt M V, et al. Bacteriology of normal and infected conjunctiva. J Clin Microbiol 1975; 1: 147–149, [PUBMED], [INFOTRIEVE], [CSA]
- Speaker M G, Milch F A, Shah M K, et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991; 98(5)639–649, [PUBMED], [INFOTRIEVE], [CSA]
- Izquierdo N, Diaz Mendoza S, Townsend W, et al. Prevalence of the microbiologic flora in contact lens wearers at the Puerto Rico Medical Center. J Bol Assoc Med P R 1991; 83(3)96–98, [CSA]
- Willcox M DP, Stapleton F. Ocular bacteriology. Rev Med Micro. 1996; 7: 123–131, [CSA]
- Leitch E C, Harmis N Y, Corrigan K M, Willcox M D. Identification and enumeration of staphylococci from the eye during soft contact lens wear. Optom Vis Sci. 1998; 75: 258–265, [PUBMED], [INFOTRIEVE], [CSA]
- Sotozono C, Inagaki K, Fujita A, et al. Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea. Cornea. 2002; 21: S94–101, [PUBMED], [INFOTRIEVE], [CSA]
- Hyndiuk R A, Eiferman R A, Caldwell D R, et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmology 1996; 103: 1854–1862, [PUBMED], [INFOTRIEVE], [CSA]
- Tabbara K F, El-Sheikh H F, Islam S M, Hammouda E. Treatment of acute bacterial conjunctivitis with topical lomefloxacin 0.3% compared to topical ofloxacin 0.3%. Eur J Ophthalmol 1999; 9: 269–275, [PUBMED], [INFOTRIEVE], [CSA]
- Tavakkoli H, Sugar J. Microbial keratitis following penetrating keratoplasty. Ophthalmic Surg. 1994; 25: 356–360, [PUBMED], [INFOTRIEVE], [CSA]
- Bannerman T L, Rhoden D L, McAllister S K, et al. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol 1997; 115: 357–361, [PUBMED], [INFOTRIEVE], [CSA]
- Wong T, Ormonde S, Gamble G, McGhee C N. Severe infective keratitis leading to hospital admission in New Zealand. Br J Ophthalmol 2003; 87: 1103–1108, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bode D D, Jr, Gelender H, Forster R K. A retrospective review of endophthalmitis due to coagulase-negative staphylococci. Br J Ophthalmol 1985; 69: 915–919, [PUBMED], [INFOTRIEVE], [CSA]
- Driebe W T, Jr, Mandelbaum S, Forster R K, et al. Pseudophakic endophthalmitis. Diagnosis and management. Ophthalmology. 1986; 93: 442–448, [PUBMED], [INFOTRIEVE], [CSA]
- Heaven C J, Mann P J, Boase D L. Endophthalmitis following extracapsular cataract surgery: a review of 32 cases. Br J Ophthalmol 1992; 76: 419–423, [PUBMED], [INFOTRIEVE], [CSA]
- Shrader S K, Band J D, Lauter C B, Murphy P. The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis 1990; 162: 115–120, [PUBMED], [INFOTRIEVE], [CSA]
- Aaberg T M, Jr, Flynn H W, Jr, Schiffman J, et al. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. J Ophthalmol 1998; 105: 1004–1010, [CSA]
- Callegan M C, Engelbert M, Parke D W, 2nd, et al. Bacterial endophthalmitis: Epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev. 2002; 15: 111–124, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Beigi B, Westlake W, Mangelschots E, et al. Peroperative microbial contamination of anterior chamber aspirates during extracapsular cataract extraction and phacoemulsification. Br J Ophthalmol 1997; 81: 953–955, [PUBMED], [INFOTRIEVE], [CSA]
- Kattan H M, Flynn H W, Jr, Pflugfelder S C, et al. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology 1991; 98: 227–238, [PUBMED], [INFOTRIEVE], [CSA]
- Kato T, Hayasaka S. Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci from conjunctivas of preoperative patients. Jpn J Ophthalmol 1998; 42: 461–465, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Peyman G A, Sathar M L, May D R. Intraocular gentamicin as intraoperative prophylaxis in South India eye camps. Br J Ophthalmol 1977; 61: 260–262, [PUBMED], [INFOTRIEVE], [CSA]
- Baum J, Peyman G A, Barza M. Intravitreal administration of antibiotic in the treatment of bacterial endophthalmitis. III. Consensus. Survey. Ophthalmology 1982; 26: 204–206, [CSA]
- Fisher J P, Civiletto S E, Forster R K. Toxicity, efficacy, and clearance of intravitreally injected of cefazolin. Arch Ophthalmol 1982; 100: 650–652, [PUBMED], [INFOTRIEVE], [CSA]
- Hopen G, Mondino B J, Kozy D, Lipkowitz J. Intraocular lenses and experimental bacterial endophthalmitis. Am J Ophthalmol 1982; 94: 402–407, [PUBMED], [INFOTRIEVE], [CSA]
- Rutgard J J, Berkowitz R A, Peyman G A. Intravitreal cephalothin in experimental staphylococcal endophthalmitis. Ann Ophthalmol 1978; 10: 293–298, [PUBMED], [INFOTRIEVE], [CSA]
- Smith M A, Sorenson J A, Lowy F D, et al. Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin. Ophthalmology 1986; 93: 1328–1335, [PUBMED], [INFOTRIEVE], [CSA]
- Gan I M, van Dissel J T, Beekhuis W H, et al. Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis. Br J Ophthalmol 2001; 85: 1289–1293, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ferro J F, de-Pablos M, Logrono M J, et al. Postoperative contamination after using vancomycin and gentamicin during phacoemulsification. Arch Ophthalmol 1997; 115: 165–170, [PUBMED], [INFOTRIEVE], [CSA]
- Fleischer A B, Hoover D L, Khan J A, et al. Topical vancomycin formulation for methicillin-resistant Staphylococcus epidermidis blepharoconjuctivitis. Am J Ophthalmol 1986; 101: 283–287, [PUBMED], [INFOTRIEVE], [CSA]
- Goodman D F, Gottsch J D. Methicillin-resistant Staphylococcus epidermidis keratitis treated with vancomycin. Arch Ophthalmol. 1988; 106: 1570–1571, [PUBMED], [INFOTRIEVE], [CSA]
- Maffett M, O'Day D M. Ciprofloxacin-resistant bacterial keratitis. Am J Ophthalmol 1993; 115: 545–546, [PUBMED], [INFOTRIEVE], [CSA]
- Axer-Siegel R, Stiebel-Kalish H, Rosenblatt I, et al. Cystoid macular edema after cataract surgery with intraocular vancomycin. Ophthalmology 1999; 106: 1660–1664, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- JA W., Kusuma C, Mond J J, Kokai-Kun J F. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 2003; 47(11)3407–3414, [CSA], [CROSSREF]
- Schindler C A, Schuhart V T. Lysostaphin: A new bacteriolytic agent for the Staphylococcus. Proc Natl Acad Sci USA 1965; 51: 414–421, [CSA]
- Dajcs J J, Hume E B, Moreau J M, et al. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit. Invest Ophthalmol Vis Sci 2000; 41: 1432–1437, [PUBMED], [INFOTRIEVE], [CSA]
- Dajcs J J, Thibodeaux B A, Hume E B, et al. Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit. Curr Eye Res 2001; 22: 451–457, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dajcs J J, Thibodeaux B A, Girgis D O, et al. Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit. Invest Ophthalmol Vis Sci 2002; 43: 3712–3716, [PUBMED], [INFOTRIEVE], [CSA]